377 related articles for article (PubMed ID: 28352231)
1. New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds.
Redondo-Blanco S; Fernández J; Gutiérrez-Del-Río I; Villar CJ; Lombó F
Front Pharmacol; 2017; 8():109. PubMed ID: 28352231
[TBL] [Abstract][Full Text] [Related]
2. Natural compounds and combination therapy in colorectal cancer treatment.
Rejhová A; Opattová A; Čumová A; Slíva D; Vodička P
Eur J Med Chem; 2018 Jan; 144():582-594. PubMed ID: 29289883
[TBL] [Abstract][Full Text] [Related]
3. Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-Resistance.
Gavrilas LI; Cruceriu D; Mocan A; Loghin F; Miere D; Balacescu O
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009495
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
5. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
6. Natural products for treating colorectal cancer: A mechanistic review.
Huang XM; Yang ZJ; Xie Q; Zhang ZK; Zhang H; Ma JY
Biomed Pharmacother; 2019 Sep; 117():109142. PubMed ID: 31238258
[TBL] [Abstract][Full Text] [Related]
7. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus.
Gao H; Zhang X; Ding Y; Qiu R; Hong Y; Chen W
Technol Cancer Res Treat; 2019; 18():1533033819853290. PubMed ID: 31138083
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer.
Gavrilas LI; Cruceriu D; Ionescu C; Miere D; Balacescu O
Food Funct; 2019 Jun; 10(6):3717-3726. PubMed ID: 31169275
[TBL] [Abstract][Full Text] [Related]
11. Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.
Yin TF; Wang M; Qing Y; Lin YM; Wu D
World J Gastroenterol; 2016 Aug; 22(31):7058-68. PubMed ID: 27610016
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms.
de Oliveira Júnior RG; Christiane Adrielly AF; da Silva Almeida JRG; Grougnet R; Thiéry V; Picot L
Fitoterapia; 2018 Sep; 129():383-400. PubMed ID: 29476786
[TBL] [Abstract][Full Text] [Related]
13. The novel heterocyclic trioxirane [(1,3,5-tris oxiran-2-yl)methyl)-1,3,5-triazinane-2,4,6-trione (TATT)] exhibits a better anticancer effect than platinum-based chemotherapy by induction of apoptosis and curcumin further enhances its chemosensitivity.
Su CL; Wang YT; Chang MH; Fang K; Chen K
Cell Biochem Biophys; 2014 Apr; 68(3):597-609. PubMed ID: 24078402
[TBL] [Abstract][Full Text] [Related]
14. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
16. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
[TBL] [Abstract][Full Text] [Related]
17. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer.
Jalili-Nik M; Soltani A; Moussavi S; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
J Cell Physiol; 2018 Sep; 233(9):6337-6345. PubMed ID: 29219177
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
19. Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature.
Millimouno FM; Dong J; Yang L; Li J; Li X
Cancer Prev Res (Phila); 2014 Nov; 7(11):1081-107. PubMed ID: 25161295
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
